Research Library

Price increases are the biggest driver of rising emergency room visit costs across the U.S., according to research led by the Center for Health and Biosciences' Vivian Ho and Sasathorn Tapaneeyakul.

The unproven stem cell intervention industry is a worldwide, direct-to-consumer market where clinics offer stem cells or stem cell-derived components to patients with little to no scientific or clinical basis. In this paper, the authors call for the establishment of a World Health Organization Expert Advisory Committee on Regenerative Medicine to tackle this issue and provide guidance. Stem Cell Reports: https://doi.org/10.1016/j.stemcr.2021.05.004

The results of this study suggest that Medicare Data on Provider Practice and Specialty, which costs less to obtain than from a for-profit data source, can be used to reliably track the cost and quality effects of vertical integration between hospitals and physicians.